Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials
- DOI
- 10.1093/oncolo/oyaf263
- Published
- 2025-08-21
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyaf263,
title = {Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials},
author = {Andrea Blasco and Sara López-Tarruella and Ander Urruticoechea and Eva Carrasco and Gonzalo Spera and Miguel Martín and Begoña Bermejo and Linnea Chap and Manuel Ruiz-Borrego and John Crown and Jose A García-Saenz and Arlene Chan and Ángel Guerrero-Zotano and Vladimir Semiglazov and Lourdes Calvo and Tadeusz Pienkowski and Jesús Herranz and Dennis Slamon},
year = {2025},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyaf263},
url = {https://doi.org/10.1093/oncolo/oyaf263}
}RIS
TY - JOUR TI - Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials AU - Andrea Blasco AU - Sara López-Tarruella AU - Ander Urruticoechea AU - Eva Carrasco AU - Gonzalo Spera AU - Miguel Martín AU - Begoña Bermejo AU - Linnea Chap AU - Manuel Ruiz-Borrego AU - John Crown AU - Jose A García-Saenz AU - Arlene Chan AU - Ángel Guerrero-Zotano AU - Vladimir Semiglazov AU - Lourdes Calvo AU - Tadeusz Pienkowski AU - Jesús Herranz AU - Dennis Slamon PY - 2025 JO - The Oncologist DO - 10.1093/oncolo/oyaf263 UR - https://doi.org/10.1093/oncolo/oyaf263 ER -
APA
Blasco, A., López-Tarruella, S., Urruticoechea, A., Carrasco, E., Spera, G., Martín, M., Bermejo, B., Chap, L., Ruiz-Borrego, M., Crown, J., García-Saenz, J. A., Chan, A., Guerrero-Zotano, Á., Semiglazov, V., Calvo, L., Pienkowski, T., Herranz, J., & Slamon, D. (2025). Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials. The Oncologist. https://doi.org/10.1093/oncolo/oyaf263
Source records
- crossref · retrieved 2026-09-25T22:50:01.473Z